Mega Genomics (06667.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

May30

Mein Gene Receives Listing Resumption Guidelines from Exchange

13:10

May5

Main Gene Proposes to Dismiss EY as Auditors

10:59

Apr21

Meiying Gene Suspends Stock Trading for Financial Verification

23:22

Mar31

Meigen Gene Delays 2024 Annual Results Release, Trading Suspension

23:22

Mar23

Mega Genomics to Release FY2024 Annual Earnings on March 31, 2025 (BJT)

00:30

Feb27

Meigen Gene to Repurchase 570,400 Shares for HKD 4.443 Million on February 27, 2025

12:36

Schedules & Filings

Schedules

Filings

Sep30

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Mar31

Earning Release(CST)

FY2024 Annual Earning Release

Aug30

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 57.64 M, Net Income 19.86 M, EPS 0.0947

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More